NO982092D0 - 5-fenyl-3-(piperidin-4-yl)-1,3,4-oksadiazol-2(3H)-on-derivater for anvendelse som 5-HT4 eller H3 reseptorligander - Google Patents

5-fenyl-3-(piperidin-4-yl)-1,3,4-oksadiazol-2(3H)-on-derivater for anvendelse som 5-HT4 eller H3 reseptorligander

Info

Publication number
NO982092D0
NO982092D0 NO982092A NO982092A NO982092D0 NO 982092 D0 NO982092 D0 NO 982092D0 NO 982092 A NO982092 A NO 982092A NO 982092 A NO982092 A NO 982092A NO 982092 D0 NO982092 D0 NO 982092D0
Authority
NO
Norway
Prior art keywords
oxadiazole
piperidin
phenyl
derivatives
receptor ligands
Prior art date
Application number
NO982092A
Other languages
English (en)
Other versions
NO309606B1 (no
NO982092L (no
Inventor
Samir Jegham
Alistair Lochead
Fruduric Galli
Alain Nedelec
Axelle Solignac
Laurence De Cruz
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9513253A external-priority patent/FR2741070B1/fr
Priority claimed from FR9513252A external-priority patent/FR2741069B1/fr
Priority claimed from FR9602663A external-priority patent/FR2745574B1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO982092D0 publication Critical patent/NO982092D0/no
Publication of NO982092L publication Critical patent/NO982092L/no
Publication of NO309606B1 publication Critical patent/NO309606B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO982092A 1995-11-09 1998-05-07 5-fenyl-3-(piperidin-4-yl)-1,3,4-oksadiazol-2(3H)-on- derivater, deres fremstilling, og medikamenter og farmasöytiske preparater NO309606B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9513253A FR2741070B1 (fr) 1995-11-09 1995-11-09 Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR9513252A FR2741069B1 (fr) 1995-11-09 1995-11-09 Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR9602663A FR2745574B1 (fr) 1996-03-04 1996-03-04 Derives de 5-phenyl-3-(piperidin-4-yl)-1, 3, 4-oxadiazol-2 (3h)-one, leur preparation et leur application en therapeutique
PCT/FR1996/001730 WO1997017345A1 (fr) 1995-11-09 1996-11-05 Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h¿3?

Publications (3)

Publication Number Publication Date
NO982092D0 true NO982092D0 (no) 1998-05-07
NO982092L NO982092L (no) 1998-06-29
NO309606B1 NO309606B1 (no) 2001-02-26

Family

ID=27253120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982092A NO309606B1 (no) 1995-11-09 1998-05-07 5-fenyl-3-(piperidin-4-yl)-1,3,4-oksadiazol-2(3H)-on- derivater, deres fremstilling, og medikamenter og farmasöytiske preparater

Country Status (29)

Country Link
US (1) US5929089A (no)
EP (1) EP0863897B1 (no)
JP (1) JP4263240B2 (no)
CN (1) CN1077891C (no)
AR (1) AR004708A1 (no)
AT (1) ATE181328T1 (no)
AU (1) AU707325B2 (no)
BG (1) BG63463B1 (no)
BR (1) BR9611311A (no)
CA (1) CA2236357C (no)
CO (1) CO4770968A1 (no)
CZ (1) CZ287268B6 (no)
DE (1) DE69602970T2 (no)
EE (1) EE03487B1 (no)
ES (1) ES2135934T3 (no)
GR (1) GR3030823T3 (no)
HU (1) HUP0001168A3 (no)
IL (1) IL124364A (no)
MX (1) MX9803696A (no)
NO (1) NO309606B1 (no)
NZ (1) NZ321626A (no)
PL (1) PL186204B1 (no)
RU (1) RU2167160C2 (no)
SI (1) SI0863897T1 (no)
SK (1) SK282335B6 (no)
TR (1) TR199800827T2 (no)
TW (1) TW371303B (no)
UA (1) UA50748C2 (no)
WO (1) WO1997017345A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
FR2762316B1 (fr) * 1997-04-18 1999-12-17 Sanofi Synthelabo Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2763068B1 (fr) * 1997-05-06 1999-06-04 Synthelabo Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
AU7658798A (en) * 1997-05-06 1998-11-27 Synthelabo 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
GB9715816D0 (en) * 1997-07-25 1997-10-01 Black James Foundation Histamine H receptor ligands
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
ATE310566T1 (de) 1998-09-18 2005-12-15 Alcon Mfg Ltd 5ht2-agoniste zur behandlung des glaukoms
WO2000064441A2 (en) * 1999-04-28 2000-11-02 Respiratorius Ab Compound for use as a medicament for treatment of disorders involving bronchocontraction
CN1355698A (zh) * 1999-06-15 2002-06-26 呼吸器有限公司 可用作治疗有关支气管收缩的机能障碍的药物的化合物
ES2260276T3 (es) 2000-08-08 2006-11-01 Ortho-Mcneil Pharmaceutical, Inc. Ariloxialquilaminas no imidazolicas como ligandos del receptor h3.
ATE323076T1 (de) 2000-08-08 2006-04-15 Ortho Mcneil Pharm Inc Bicyclische verbindungen als h3 rezeptor liganden
ATE354568T1 (de) * 2000-08-08 2007-03-15 Ortho Mcneil Pharm Inc Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden
ATE449090T1 (de) 2001-07-02 2009-12-15 High Point Pharmaceuticals Llc Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
EP1434765B1 (en) * 2001-09-14 2009-12-02 High Point Pharmaceuticals, LLC Substituted piperidines with selective binding to histamine h3-receptor
ATE479655T1 (de) 2001-09-14 2010-09-15 High Point Pharmaceuticals Llc Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US7064135B2 (en) 2001-10-12 2006-06-20 Novo Nordisk Inc. Substituted piperidines
WO2003031432A1 (en) 2001-10-12 2003-04-17 Novo Nordisk A/S Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
CA2469663A1 (en) 2001-12-14 2003-06-26 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
US7332508B2 (en) 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
GB0325956D0 (en) * 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
CA2569654C (en) 2004-06-15 2010-12-21 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
MX2007015675A (es) 2005-07-04 2008-02-20 Novo Nordisk As Antagonistas del receptor de histamina h3.
EP1959951B1 (en) * 2005-12-01 2009-12-23 F. Hoffmann-la Roche AG Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
EP2402324A1 (en) 2006-05-29 2012-01-04 High Point Pharmaceuticals, LLC Benzodioxolylcyclopropylpiperazinylpyridazines
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
PT2758394E (pt) 2011-09-19 2015-04-22 Suven Life Sciences Ltd Compostos heteroarilo como ligandos de recetores 5-ht4

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055476A (en) * 1990-08-13 1991-10-08 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
WO1993003725A1 (en) * 1991-08-20 1993-03-04 Smithkline Beecham Plc 5-ht4 receptor antagonists
SG49153A1 (en) * 1991-09-12 1998-05-18 Smithkline Beecham Plc 5-HT4 receptor antagonists
EP0625149A1 (en) * 1992-02-06 1994-11-23 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists
GB9219163D0 (en) * 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
JPH06157518A (ja) * 1992-11-27 1994-06-03 Yamanouchi Pharmaceut Co Ltd 新規なオキサジアゾール誘導体又はその塩

Also Published As

Publication number Publication date
DE69602970D1 (de) 1999-07-22
JP2000500125A (ja) 2000-01-11
PL186204B1 (pl) 2003-11-28
HUP0001168A2 (hu) 2001-04-28
ES2135934T3 (es) 1999-11-01
PL326671A1 (en) 1998-10-12
EE03487B1 (et) 2001-08-15
CA2236357A1 (en) 1997-05-15
UA50748C2 (uk) 2002-11-15
AR004708A1 (es) 1999-03-10
ATE181328T1 (de) 1999-07-15
NO309606B1 (no) 2001-02-26
US5929089A (en) 1999-07-27
MX9803696A (es) 1998-09-30
GR3030823T3 (en) 1999-11-30
RU2167160C2 (ru) 2001-05-20
AU7500196A (en) 1997-05-29
EP0863897A1 (fr) 1998-09-16
BG102412A (en) 1999-08-31
CN1202169A (zh) 1998-12-16
SK59998A3 (en) 1998-11-04
BR9611311A (pt) 1999-06-29
DE69602970T2 (de) 2000-01-20
SK282335B6 (sk) 2002-01-07
WO1997017345A1 (fr) 1997-05-15
CZ287268B6 (en) 2000-10-11
CN1077891C (zh) 2002-01-16
IL124364A0 (en) 1998-12-06
HUP0001168A3 (en) 2001-07-30
CZ142198A3 (cs) 1998-08-12
JP4263240B2 (ja) 2009-05-13
NZ321626A (en) 1998-10-28
TW371303B (en) 1999-10-01
EP0863897B1 (fr) 1999-06-16
CO4770968A1 (es) 1999-04-30
IL124364A (en) 2001-08-08
BG63463B1 (bg) 2002-02-28
NO982092L (no) 1998-06-29
AU707325B2 (en) 1999-07-08
HK1016165A1 (en) 1999-10-29
TR199800827T2 (xx) 1999-02-22
CA2236357C (en) 2006-10-17
SI0863897T1 (en) 1999-10-31
EE9800155A (et) 1998-12-15

Similar Documents

Publication Publication Date Title
NO982092D0 (no) 5-fenyl-3-(piperidin-4-yl)-1,3,4-oksadiazol-2(3H)-on-derivater for anvendelse som 5-HT4 eller H3 reseptorligander
DK0873309T3 (da) 3-spiro-indolin-2-on-derivater, som vasopressin- og/eller ocytocin-receptorligander
ATE201016T1 (de) Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten
NO991560D0 (no) PDE IV som inhiberer 2-cyanoiminoimidazol-derivater
FR2637796B1 (fr) Charniere pour abattant de w.c.
NO995040L (no) 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander
FI963297A0 (fi) Antifungaalisia triatsolijohdannaisia sisältävät emulsiot
NO985970D0 (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
NO911200L (no) Fremgangsmaate for fremstilling av selektive adenosin-receptor midler.
NO985972D0 (no) Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
FI943872A0 (fi) 2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina
ITRM970167U4 (it) Sedile per wc
AU7578396A (en) Substituted tetrahydropyridine derivatives acting on 5-ht receptors
FI973245A0 (fi) Verisuonia supistavat substituoidut 2,3-dihydro-1,4-dioksinopyridiinit
DK0863897T3 (da) Derivater af 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-on, som kan anvendes som ligander for 5-HT4- eller H3-recept
FR2627687B1 (fr) Protection temporaire pour les abattants de cuvette de w.c.
NO894707D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
FR2671476B1 (fr) Abattant de w.c. amovible.
ZA9600758D (en) Idole derivatives as 5-ht receptor antagonist.
SE9100354D0 (sv) Sitsanordning foer wc-stol
FI903662A7 (fi) Tvaettbassaeng foer wc-stol.
IT8883466A0 (it) Sedile sterilizzabile per tazza wc
SE9201917D0 (sv) Sitsanordning foer wc-stol
IT8830632V0 (it) Sedile da w.c. termico.
ITMO950042U1 (it) Supporto pieghevole o scomponibile per bicicletta.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees